ConferencePoster
 (2022)

A multicohort, open-label, phase 2 basket study of the coformulation of vibostolimab with pembrolizumab, with or without other anticancer therapies, in select solid tumors

Lugowska, Iwona; Rojas, Carlos; Falcon, Alejandro; Gonzalez, Lucia; Hsu, Chih-Hung; Yen, Chia-Jui; Rha, Sun Young; Yonemori, Kan; Li, Daneng; Geva, Ravit; Salman, Pamela